行情

NNVC

NNVC

NANOVIRICIDES
AMEX

实时行情|Nasdaq Last Sale

4.270
-0.140
-3.17%
盘后: 4.280 +0.01 +0.23% 16:00 06/14 EDT
开盘
4.520
昨收
4.410
最高
4.520
最低
4.190
成交量
7.91万
成交额
--
52周最高
9.97
52周最低
2.850
市值
4,924.14万
市盈率(TTM)
-4.9883
分时
5日
1月
3月
1年
5年
纳米杀虫剂第三季度每股收益从去年同期的(1.24)美元升至(0.19)美元
Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.19) per share. This is a 84.68 percent increase over losses of $(1.24) per share from the same period last year.
Benzinga · 05/17 10:50
埃博拉疫苗:为什么要花这么长时间
Efforts to develop an Ebola vaccine have been in the works for some time. But experts say it's unlikely to see one available anytime soon.
CNBC.com · 04/17 00:31
病毒性结膜炎管道药物市场报告2021年增长因素,受COVID-19影响的研究方法和2026年全球预测
Apr 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Viral Conjunctivitis Pipeline Drugs...
The Express Wire · 04/12 08:55
病毒性结膜炎管道药物市场份额,增长,规模2021年:全球销售收入,新兴技术,关键参与者分析,发展状况,机会评估和行业扩张策略2027年
The Express Wire · 04/07 05:53
2021年全球电晕病毒治疗市场分析,按份额,规模,行业需求,全球研究,知名企业,新兴趋势,投资机会和到2026年的收入预期
Apr 05, 2021 (The Expresswire) -- Global Corona Virus Treatment Market Research Report 2021: The Global Corona Virus Treatment Market report provides revenue...
The Express Wire · 04/05 10:47
Ameco Research的2020-2027年甲型流感病毒,H3N2亚型感染药物市场收入,趋势,增长,份额,规模和预测
pune, India, Tue, 30 Mar 2021 02:46:55 / Comserve Inc. / -- Ameco Research indicates that the Global Influenza A Virus, H3N2 Subtype Infections Drug Market...
Comserve · 03/31 13:09
2015-2026年全球H3N2感染治疗市场洞察力,概述,分析和预测
Mar 30, 2021 (Heraldkeepers) -- This report researches the worldwide H3N2 Infection Treatment market size (value) in key regions like United States, Europe,...
Heraldkeepers · 03/30 16:22
到2026年纳米结构药物市场概况,新机遇和SWOT分析辉瑞,Moderna,NanoViricides,Celgene
Mar 12, 2021 (Market Insight Reports) -- Nanostructured Drug Market Comprehensive Study is an expert and top to bottom investigation on the momentum...
Market Insight Reports · 03/12 13:32
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解NNVC最新的财务预测,通过NNVC每股收益,每股净资产,每股现金流等数据分析NANOVIRICIDES近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测NNVC价格均价为14.50,最高价位14.50,最低价为14.50。
EPS
机构持股
总机构数: 38
机构持股: 304.64万
持股比例: 26.48%
总股本: 1,150.50万
类型机构数股数
增持
3
8.58万
建仓
2
2.51万
减持
6
17.38万
平仓
4
142.46万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-0.04%
制药与医学研究
+0.07%
高管信息
Chairman/President/Executive Director
Anil Diwan
Chief Financial Officer
Meeta Vyas
Independent Director
Stanley Glick
Independent Director
Makarand Jawadekar
Independent Director
Theodore Rokita
Independent Director
Brian Zucker
暂无数据
NNVC 简况
NanoViricides, Inc. is a nano-biopharmaceutical research and development company. The Company is engaged the discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company provides nanoviricide technology, which enables direct attacks at multiple points on a virus particle. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection. The nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company’s lead product candidate is NV-HHV-101 in the HerpeCide program, as a skin cream for the treatment of shingles rash.

微牛提供NanoViricides Inc(AMEX-NNVC)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NNVC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NNVC股票基本功能。